Latest News by Industry
SAN DIEGO (AP) — SAN DIEGO (AP) — Mirati Therapeutics Inc. (MRTX) on Tuesday reported a loss of $184.6 million in its first quarter.
On a per-share basis, the San Diego-based company said it had a loss of $3.18.
The results surpassed Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of $3.47 per share.
The biopharmaceutical company posted revenue of $7.2 million in the period, which also beat Street forecasts. Seven analysts surveyed by Zacks expected $5.1 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a MRTX">Zacks stock report on MRTX at https://www.zacks.com/ap/MRTX